Immunological basis of inflammatory bowel disease: Role of the microcirculation

Microcirculation

Volumn 8, Issue 5, 2001, Pages 283-301

  Laroux, F Stephen ^a   Grisham, Matthew B ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Adhesion molecules; Blood flow; Crohn's disease; Edema; Free radicals; Leukocytes; Nitric oxide; Regulatory cells; T lymphocytes; Ulcerative colitis; Vasculature

Indexed keywords

ANIMAL; CELLULAR IMMUNITY; COLITIS; CYTOLOGY; ENTERITIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; MICROCIRCULATION; PATHOLOGY; PHYSIOLOGY; REVIEW; SECRETION; VASCULAR ENDOTHELIUM;

ANIMALS; COLITIS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; INFLAMMATORY BOWEL DISEASES; MICROCIRCULATION;

EID: 0035487682     PISSN: 10739688     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mn.7800095     Document Type: Review

References (104)

1. Abbas AK. (1994). Cellular and Molecular Immunology. Saunders, Philadelphia.
2. Allen AC. (1971). A unified concept of the vascular pathogenesis of enterocolitis of varied etiology. A pathophysiologic analysis. Am J Gastroenterol 55: 347-378.
3. Arfors KE, Rutili G, Svensjo E. (1979). Microvascular transport of macromolecules in normal and inflammatory conditions. Acta Physiol Scand Suppl 463:93-103.
4. Bacaner MB. (1966). Quantitative measurement of regional colon blood flow in the normal and pathological human bowel. Gastroenterology 51:764-777.
5. Beckman JS, Koppenol WH. (1996). Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437.
6. Bendjelloul F, Maly P, Mandys V, Jirkovska M, Prokesova L, Tuckova L, Tlaskalova-Hogenova H. (2000). Intercellular adhesion molecule-1 (ICAM-1) deficiency protects mice against severe forms of experimentally induced colitis. Clin Exp Immunol 119: 57-63.
7. Bennett CF, Kornbrust D, Henry S, Stecker K, Howard R, Cooper S, Dutson S, Hall W, Jacoby HI. (1997). An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 280:988-1000.
8. Berg DJ, Davidson N, Kuhn R, Muller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D. (1996). Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TII1-like responses. J Clin Invest 98:1010-1020.
9. Berlin C, Bargatze RF, Campbell JJ, von Andrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC. (1995). Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422.
10. Bienvenu K, Harris N, Granger DN. (1994). Modulation of leukocyte migration in mesenteric interstitium. Am J Physiol 267:H1573-H1577.
11. Binion DG, West GA, Ina K, Ziats NP, Emancipator SN, Fiocchi C. (1997). Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 112: 1895-1907.
12. Boijsen E, Hartel M. (1973). [Contrast flow rates in the superior mesenteric arterial territory]. Fortschr Geb Rontgenstr Nuklearmed 118:491-498.
13. Bolondi L, Gaiani S, Brignola C, Campieri M, Rigamonti A, Zironi G, Gionchetti P, Belloli C, Miglioli M, Barbara L. (1992). Changes in splanchnic hemodynamics in inflammatory bowel disease. Non-invasive assessment by Doppler ultrasound flowmetry. Scand J Gastroenterol 27:501-507.
14. Brahme F, Lindstrom C. (1970). A comparative radiographic and pathological study of intestinal vasoarchitecture in Crohn's disease and in ulcerative colitis. Gut 11:928-940.
15. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ. (1997). Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 151:97-110.
16. Butcher EC, Picker LJ. (1996). Lymphocyte homing and homeostasis. Science 272:60-66.
17. Butcher EC, Williams M, Youngman K, Rott L, Briskin M. (1999). Lymphocyte trafficking and regional immunity. Adv Immunol 72:209-253.
18. Carlos TM, Harlan JM. (1990). Membrane proteins involved in phagocyte adherence to endothelium. Immunol. Rev 114:5-28.
19. Chan PY, Aruffo A. (1993). VLA-4 integrin mediates lymphocyte migration on the inducible endothelial cell ligand VCAM-1 and the extracellular matrix ligand fibronectin. J Biol Chem 268:24655-24664.
20. Conner EM, Eppihimer MJ, Morise Z, Granger DN, Grisham MB. (1999). Expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in acute and chronic inflammation. J Leukoc Biol 65: 349-355.
21. D'Agata ID, Paradis K, Chad Z, Bonny Y, Seidman E. (1996). Leucocyte adhesion deficiency presenting as a chronic ileocolitis. Gut 39:605-608.
22. Del Gaudio A, Bragaglia RB, Boschi L, Del Gaudio GA, Accorsi D. (1997). A new approach in the management of Crohn's disease: observations in 20 consecutive cases. Hepatogastroenterology 44:1095-1103.
23. Elson CO, Cong Y, Brandwein S, Weaver CT, McCabe RP, Mahler M, Sundberg JP, Leiter EH. (1998). Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann NY Acad Sci 859:85-95.
24. Erikson U, Fagerberg S, Krause U, Olding L. (1970). Angiographic studies in Crohn's disease and ulcerative colitis. Am J Roentgenol Radium Ther Nucl Med 110:385-392.
25. Fiocchi C. (1998). Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205.
26. Gannon BJ, Perry MA. (1989). Histoanatomy and ultrastructure of vasculature of alimentary tract. In: The Gastrointestinal System, 6th ed. (SG Schultz, BB Rauner, and JD Wood, Eds.) American Physiological Society, Bethesda, MD.
27. Gordon S. (1998). The role of the macrophage in immune regulation. Res Immunol 149:685-688.
28. Granger DN. (1998). Physiology and pathophysiology of the microcirculation. Dialogues in Cardiovascular Medicine 3:123-140.
29. Granger DN, Barrowman JA. (1983). Microcirculation of the alimentary tract 1. Physiology of transcapillary fluid and solute exchange. Gastroenterology 84:846-868.
30. Granger DN, Barrowman JA. (1983). Microcirculation of the alimentary tract. II. Pathophysiology of edema. Gastroenterology 84:1035-1049.
31. Granger DN, Kubes P. (1994). The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 55:662-675.
32. Grisham MB. (1994). Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861.
33. Grisham MB, Jourd'Heuil D, Wink DA. (1999). Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 276:G315-G321.
34. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG. (1997). A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737-742.
35. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P. (1996). Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 156:2558-2565.
36. Hesterberg PE, Winsor-Hines D, Briskin MJ, Soler-Ferran D, Merrill C, Mackay CR, Newman W, Ringler DJ. (1996). Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin alpha 4 beta 7. Gastroenterology 111:1373-1380.
37. Hollander GA, Simpson SJ, Mizoguchi E, Nichogiannopoulou A, She J, Gutierrez-Ramos JC, Bhan AK, Burakoff SJ, Wang B, Terhorst C. (1995). Severe colitis in mice with aberrant thymic selection. Immunity 3:27-38.
38. Hulten L, Lindhagen J, Lundgren O, Fasth S, Ahren C. (1977). Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology 72:388-396.
39. Johansson H, Krause U, Olding L. (1972). Microangiographic studies in Crohn's disease and ulceralive colitis. Acta Chir Scand 138:409-414.
40. Johnson LR. (1994). Physiology of the Gastrointestinal Tract. Raven Press, New York.
41. Jones SC, Banks RE, Haidar A, Gearing AJ, Hemingway IK, Ibbotson SH, Dixon MF, Axon AT. (1995). Adhesion molecules in inflammatory bowel disease. Gut 36:724-730.
42. Kalima TV. (1971). The structure and function of intestinal lymphatics and the influence of impaired lymph flow on the ileum of rats. Scand J Gastroenterol Suppl 10:1-87.
43. Kawachi S, Cockrell A, Laroux FS, Gray L, Granger DN, van der Heyde HC, Grisham MB. (1999). Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation. Am J Physiol 277:G572-G576.
44. Kawachi S, Jennings S, Panes J, Cockrell A, Laroux FS, Gray L, Perry M, van der Heyde H, Balish E, Granger DN, Specian RA, Grisham MB. (2000). Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice. Am J Physiol Gastrointest Liver Physiol 278:G734-G743.
45. Kawachi S, Morise Z, Conner E, Laroux FS, Gray L, Fuseler J, Grisham MB. (2000). E-selectin expression in a marine model of chronic colitis. Biochem Biophys Res Commun 268:547-552.
46. Kawachi S, Morise Z, Jennings SR, Conner E, Cockrell A, Laroux FS, Chervenak RP, Wolcott M, van der Heyde H, Gray L, Feng L, Granger DN, Specian RA, Grisham MB. (2000). Cytokine and adhesion molecule expression in SCID mice reconstituted with CD4+ T Cells [in process citation]. Inflamm Bowel Dis 6:171-180.
47. Kessel RG, Kardon RH. (1979). Tissues and organs: a text-atlas of scanning electron microscopy. W.H. Freeman, San Francisco.
48. Kirsner JB. (1978). Inflammatory bowel disease. Considerations of etiology and pathogenesis. Am J Gastroenterol 69:253-271.
49. Kirsner JB. (1991). Inflammatory bowel disease. Part I: nature and pathogenesis. Dis Mon 37:605-666.
50. Kirsner JB, Shorter RG. (1995). Inflammatory Bowel Disease. Williams & Wilkins, Baltimore.
51. Knutson H, Lunderquist A, Lunderquist A. (1968). Vascular changes in Crohn's disease. Am J Roentgenol Radium Ther Nucl Med 103:380-385.
52. Koizumi M, King N, Lobb R, Benjamin C, Podolsky DK. (1992). Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology 103:840-847.
53. Kubes P, Granger DN. (1996). Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 32:699-708.
54. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. (1993). Interleukin-10-deficient mice develop chronic enterocolitis [see comments]. Cell 75:263-274.
55. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. (1993). Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774.
56. Lalani I, Bhol K, Ahmed AR. (1997). Interleukin10: biology, role in inflammation and autoimmunity [published erratum appears in Ann Allergy Asthma Immunol 1998 Mar;80(3):A-6]. Ann Allergy Asthma Immunol 79:469-483.
57. Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM. (1999). The role of IL-10 in inflammatory bowel disease: "of mice and men" [in process citation]. Toxicol Pathol 27:123-133.
58. Lopez-Cubero SO, Sullivan KM, McDonald GB. (1998). Course of Crohn's disease after allogeneic marrow transplantation [see comments]. Gastroenterology 114:433-440.
59. Lott MF, Davies JD. (1983). Lymph node hypervascularity: haemangiomatoid lesions and pan-nodal vasodilatation. J Pathol 140:209-219.
60. Lunderquist A, Knutsson H. (1967). Angiography in Crohn's disease of the small bowel and colon. Am J Roentgenol Radium Ther Nucl Med 101:338-344.
61. Mason D, Powrie F. (1998). Control of immune pathology by regulatory T cells. Curr Opin Immunol 10:649-655.
62. Mombaerts P, Mizoguchi E, Grusby MJ, Glimcher LH, Bhan AK, Tonegawa S. (1993). Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice [see comments]. Cell 75:274-282.
63. Morise Z, Eppihimer M, Granger DN, Anderson DC, Grisham MB. (1999). Effects of lipopolysaccharide on endothelial cell adhesion molecule expression in interleukin-10 deficient mice. Inflammation 23:99-110.
64. Muller WA, Weigl SA, Deng X, Phillips DM. (1993). PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 178:449-460.
65. Nakamura S, Ohtani H, Watanabe Y, Fukushima K, Matsumoto T, Kitano A, Kohayashi K, Nagura H. (1993). In situ expresson of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab Invest 69:77-85.
66. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. (1996). Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med 183:2605-2616.
67. Nicoll PA, Taylor AE. (1977). Lymph formation and flow. Annu Rev Physiol 39:73-95.
68. Nusrat A, Parkos CA, Liang TW, Carnes DK, Madara JL. (1997). Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113:1489-1500.
69. Oshitani N, Campbell A, Bloom S, Kitano A, Kobayashi K, Jewell DP. (1995). Adhesion molecule expression on vascular endothelium and nitroblue tetrazolium reducing activity in human colonic mucosa. Scand J Gastroenterol 30:915-920.
70. Pabst O, Forster R, Lipp M, Engel H, Arnold HH. (2000). NKX2.3 is required for MAdCAM-1 expression and homing of lymphocytes in spleen and mucosa-associated lymphoid tissue. EMBO J 19:2015-2023.
71. Palade GE, Simionescu M, Simionescu N. (1979). Structural aspects of the permeability of the microvascular endothelium. Acta Physiol Scand Suppl 463:11-32.
72. Panes J, Granger DN. (1998). Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114:1066-1090.
73. Picarella D, Hurlbut P, Rottman J, Shi X, Butcher E, Ringler DJ. (1997). Monoclonal antibodies specific for beta 7 integrin and mucosal adressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of SCID mice reconstituted with CD45RBhigh CD4+ T cells. J Immunol 158:2099-2106.
74. Podolsy DK, Lobb R, King N, Benjamin CD, Pepinsky B, Sehgal P, deBeaumont M. (1993). Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody. J Clin Invest 92:372-380.
75. Powrie F. (1995). T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity 8:171-174.
76. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. (1996). A critical role for transforming growth factor-beta hut not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cels. J Exp Med 183:2669-2674.
77. Powrie F, Correa-Oliveira R, Mauze S, Coffman RL. (1994). Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179: 589-600.
78. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL. (1994). Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45RBhi CD4+ cells. Immunity 1:553-562.
79. Powrie F, Mauze S, Coffman RL. (1997). CD4+ T-cells in the regulation of inflammatory responses in the intestine. Res Immunol 148:576-581.
80. Rennick D, Davidson N, Berg D. (1995). Interleukin-10 gene knock-out mice: a model of chronic inflammation. Clin Immunol Immunopathol 76:S174-S178.
81. -/- mice: an overview. J Leukoc Biol 61:389-396.
82. Romanic AM, Graesser D, Baron JL, Visintin I, Janeway CA Jr, Madri JA. (1997). T cell adhesion to endothelial cells and extracellular matrix is modulated upon transendothelial cell migration. Lab Invest 76:11-23.
83. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, Birnbaumer L. (1995). Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J Clin Immunol 15: 101S-105S.
84. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. (1993). Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene [see comments]. Cell 75:253-261.
85. Schuermann GM, Aber-Bishop AE, Facer P, Lee JC, Rampton DS, Dore CJ, Polak JM. (1993). Altered expression of cell adhesion molecules in uninvolved gut in inflammatory bowel disease. Clin Exp Immunol 94:341-347.
86. Schuermann GM, Bishop AE, Facer P, Vecchio M, Lee JC, Rampton DS, Polak JM. (1995). Increased expression of cell adhesion molecule P-selectin in active inflammatory bowel disease. Gut 36:411-418.
87. Seder RA. (1995). The role of IL 12 in the regulation of Th1 and Th2 differentiation. Res Immunol 146:473-476.
88. Seder RA, Mosmann TM. (1999). Differentiation of effector phenotypes of CD4+ and CD8+ T cells. In: Fundamental Immunology (WE Paul, Ed.) Lippincott-Raven, Philadelphia. 879-908.
89. Shimizu Y, Newman W, Gopal TV, Horgan KJ, Graber N, Beall LD, van Seventer GA, Shaw S. (1991). Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113: 1203-1212.
90. Simpson SJ, de Jong YP, Comiskey M, Terhorst C. (1998). T cells in mouse models of gut inflammation. Chem Immunol 71:118-138.
91. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC. (1989). Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest 83: 2008-2017.
92. Soriano A, Salas A, Salas A, Sans M, Gironella M, Elena M, Anderson DC, Pique JM, Panes J. (2000). VCAM-1, but not ICAM-1 or MAdCAM-1, immunoblockade ameliorates DSS-induced colitis in mice. Lab Invest 80:1541-1551.
93. Souza HS, Elia CC, Spencer J, MacDonald TT. (1999). Expression of lymphocyte-endothelial receptor-ligand pairs, alpha4beta7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease. Gut 45: 856-863.
94. Strober W, Fuss IJ, Ehrhardt RO, Neurath M, Boirivant M, Ludviksson BR. (1998). Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation. Scand J Immunol 48:453-458.
95. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M. (1997). Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation. Immunol Today 18: 61-64.
96. Strober W, Ludviksson BR, Fuss IJ. (1908). The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Ann Intern Med 128:848-856.
97. Taurog JD, Richardson JA, Croft JT, Simmons WA, Zhou M, Fernandez-Sueiro JL, Balish E, Hammer RE. (1994). The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med 180:2359-2364.
98. Trinchieri G. (1998). Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70:83-243.
99. Tsuchiya M, Miura S, Asakura H, Hibi T, Tanaka T, Aiso S, Hiramatsu K. (1980). Angiographic evaluation of vascular changes in ulcerative colitis. Angiology 31:147-153.
100. Viney JL, Fong S. (1998). Beta 7 integrins and their ligands in lymphocyte migration to the gut. Chem Immunol 71:64-76.
101. Viney JL, Jones S, Chiu HH, Lagrimas B, Renz ME, Presta LG, Jackson D, Hillan KJ, Lew S, Fong S. (1996). Mucosal addressin cell adhesion molecule-1: a structural and functional analysis demarcates the integrin binding motif. J Immunol 157:2488-2497.
102. Weiss SJ. (1989). Tissue destruction by neutrophils [see comments]. N Engl J Med 320:365-376.
103. Winn R, Vedder N, Ramamoorthy C, Sharar S, Harlan J. (1998). Endothelial and leukocyte adhesion molecules in inflammation and disease. Blood Coagul Fibrinolysis 9 suppl 2:S17-S23.
104. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL, Shanahan WR Jr. (1998). A placebo-controlled trial of ICAM-1 anti-sense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 114:1133-1142.